| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 340.04B | 303.64B | 293.40B | 270.33B | 225.10B |
| Gross Profit | 96.79B | 61.86B | 46.38B | 42.54B | 34.75B |
| EBITDA | 89.25B | 62.46B | 40.39B | 43.00B | 32.20B |
| Net Income | 51.78B | 32.05B | 21.12B | 20.04B | 15.67B |
Balance Sheet | |||||
| Total Assets | 513.93B | 396.61B | 343.01B | 306.04B | 208.59B |
| Cash, Cash Equivalents and Short-Term Investments | 75.60B | 37.69B | 24.89B | 25.34B | 17.16B |
| Total Debt | 169.84B | 129.99B | 122.83B | 123.18B | 77.30B |
| Total Liabilities | 266.67B | 218.88B | 204.64B | 181.59B | 115.70B |
| Stockholders Equity | 184.01B | 139.79B | 107.51B | 88.94B | 71.03B |
Cash Flow | |||||
| Free Cash Flow | 44.46B | 24.06B | 6.43B | 3.88B | 5.92B |
| Operating Cash Flow | 74.64B | 48.86B | 36.86B | 28.68B | 26.07B |
| Investing Cash Flow | -31.66B | -32.24B | -33.96B | -50.98B | -23.76B |
| Financing Cash Flow | -10.29B | -4.43B | -5.82B | 27.26B | 23.32M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$16.37B | 14.89 | 23.61% | 0.44% | 6.76% | 239.14% | |
72 Outperform | HK$60.05B | 22.66 | 32.65% | 1.32% | 31.24% | 58.16% | |
66 Neutral | HK$978.78B | 16.09 | 30.60% | 1.55% | 9.69% | 54.43% | |
66 Neutral | HK$36.89B | 13.75 | 33.81% | 1.40% | 70.92% | 249.45% | |
64 Neutral | HK$115.06B | 27.53 | 11.01% | 0.16% | 44.37% | 125.87% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
55 Neutral | HK$198.44B | 33.06 | ― | 0.93% | 36.74% | 36.49% |